A review of new science, in plain language

Nature Communications  ·  27 October 2026  ·  From issue 58

NK cells engineered with a chimeric antigen receptor delay HIV rebound and reshape HIV reservoir composition

In mice, engineered immune cells delayed HIV's return and shrank the variety of virus that came back.

Yuan Shi, Izra Abbaali et al.

Engineered immune cells slowed the return of HIV after treatment stopped in mice. Scientists built natural killer cells with an added sensor that spots a hidden marker on HIV-infected cells. The cells hunted and killed infected cells in lab dishes. In mice, they also cut the number of virus types that came back and pushed the leftover virus into harder-to-wake hiding spots.

What it could change Engineered immune cells cut the number and spread of HIV strains that returned after treatment stopped, in mice.

Shows a lab and mouse result, not a proven treatment for people.

Humanized mice only, no human safety or efficacy data yet.

Integrity screen: passed (3 checks) Checked 28 October 2026. Retraction record: none. DOI resolves at doi.org. Metadata record found (Nature Communications). Read the source

This screen checks process signals. It does not tell you the findings are true.

Get it free, every two days

Five papers free every issue, about 15 emails a month. No spam. Leave in one click.

Also in issue 58 15 papers
More from Nature Communications